Sonoma Pharmaceuticals (SNOA) Receivables (2016 - 2022)
Sonoma Pharmaceuticals (SNOA) has 2 years of Receivables data on record, last reported at $3.5 million in Q4 2012.
- For Q4 2012, Receivables rose 82.67% year-over-year to $3.5 million; the TTM value through Dec 2012 reached $3.5 million, up 82.67%, while the annual FY2012 figure was $2.4 million, 16.57% up from the prior year.
- Receivables reached $3.5 million in Q4 2012 per SNOA's latest filing, up from $3.2 million in the prior quarter.
- Across five years, Receivables topped out at $3.5 million in Q4 2012 and bottomed at $1.9 million in Q4 2011.